IHH buys 55% stake in Angsana Holdings for S$9.3m
IHH Healthcare Berhad (IHH) has announced that it has subscribed for a 55 per cent equity interest (5,104,849 ordinary shares) in Angsana Holdings Pte Ltd for a total consideration of S$9.3 million.
The subscription was made through its indirect wholly owned subsidiary, Parkway Pantai Limited.
As a result, Angsana and its subsidiaries have been consolidated as indirect subsidiaries of IHH.
The principal activity of Angsana and its subsidiaries is to provide molecular diagnostic test services, including biochemistry, chemistry, haematology and molecular blood analysis and testing.
The transaction will not effect IHH's issued share capital and substantial shareholders, with no material effect on the earnings, net assets or gearing of IHH for the financial year ending Dec 31.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
OpenAI inks licensing deal with People magazine publisher
Apple unveils new AI-focused chip in upgraded iPad Pro models
DBS CEO Piyush Gupta sells S$2.7 million worth of bank shares
Disney's surprise streaming entertainment profit offset by weaker TV business
Geely, Foretellix partner to jump-start self driving car development
US: Wall Street opens slightly higher on rate cut optimism